Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02496130 · ClinicalTrials.gov registry record
Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 70
- Enrollment target
NCT02496130: Completed study, sponsored by Brigham and Women's Hospital.
NCT02496130 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 70 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02496130 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The goal of this study is to compare common methods of tissue extraction at the time of minimally invasive surgery.
Primary Outcome
Return to daily activities will be recorded on a post-operative patient activity diary recording the following tasks: a) work (if applicable), b) domestic tasks, c) driving a vehicle (if applicable) and d) physical exercise (if applicable).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-09 |
What the finished NCT02496130 record still lists
NCT02496130 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02496130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02496130 about?
NCT02496130 is a clinical study titled "Perioperative Outcomes of Common Methods of Minimally Invasive Contained Tissue Extraction". The goal of this study is to compare common methods of tissue extraction at the time of minimally invasive surgery.
What is the current status of trial NCT02496130?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2016-04. Estimated completion is 2017-09.
Who is sponsoring clinical trial NCT02496130?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia